Cover Image

Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yang Zhou, Xinru Li, Yajing Guo, Ye Wu, Lixin Yin, Luyun Tu, Sheng Hong, Hui Cai, Feiqing Ding
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	MedComm
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deleting SUV39H1 in CAR‐T cells epigenetically enhances the antitumor function
by: Yuning Wang, et al.
Published: (2024)

5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
by: Jianhua Xia, et al.
Published: (2024)

Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect
by: Xiyuan Wang, et al.
Published: (2024)

Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
by: Yan Zhang, et al.
Published: (2024)

Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
by: Fei Wang, et al.
Published: (2024)

XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection
by: Dandan Peng, et al.
Published: (2024)

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8‐Positive T‐Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study
by: Guochao Zhang, et al.
Published: (2026)

iPSC‐derived NK cells with site‐specific integration of CAR19 and IL24 at the multi‐copy rDNA locus enhanced antitumor activity and proliferation
by: Yuxuan Zhang, et al.
Published: (2024)

Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
by: Ming Zhou, et al.
Published: (2025)

Synthetic circRNA therapeutics: innovations, strategies, and future horizons
by: Jingsheng Cai, et al.
Published: (2024)

Organ Transplantation: Current Status, Challenges, and Future Prospects
by: Xinqiang Li, et al.
Published: (2026)

Booster vaccination: host preparation against Omicron challenge by innate immunity training
by: Lan Bai, et al.
Published: (2024)

Addition of anti‐PD‐1 immunotherapy to BRAF inhibitor‐based targeted therapy improves real‐world survival and delays brain metastases in patients with BRAFV600‐mutant advanced melanoma: a multicenter cohort study
by: Junwan Wu, et al.
Published: (2025)

Enhancing the effectiveness of anti‐respiratory virus vaccines by bolstering mucosal immunity and cellular defenses
by: Rubing Xue, et al.
Published: (2024)

Duchenne muscular dystrophy treatment with lentiviral vector containing mini‐dystrophin gene in vivo
by: Xiaoyu Wang, et al.
Published: (2024)

circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis
by: Lin Ji, et al.
Published: (2025)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
by: Changping Deng, et al.
Published: (2025)

A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter
by: Qian Ding, et al.
Published: (2024)

Yin Yang 1 Promotes Antiprogrammed Cell Death‐1 Resistance in Hepatocellular Carcinoma through Polypeptide N‐Acetylgalactosaminyltransferase 16‐Mediated Glycosylation of Programmed Death Ligand‐1
by: Shu‐sheng Lin, et al.
Published: (2025)

The SUMOylated RREB1 interacts with KDM1A to induce 5‐fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer
by: Ya‐Nan Deng, et al.
Published: (2025)

The efficacy and safety of stereotactic body radiotherapy combined with systematic therapy for metastatic renal cell carcinoma: a systematic review and meta‐analysis
by: Shiyu Zhang, et al.
Published: (2024)

Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross‐Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses
by: Ximeng Ma, et al.
Published: (2025)

Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity
by: Xiangxin Geng, et al.
Published: (2025)

Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study
by: Peng Zhang, et al.
Published: (2024)

Long Noncoding RNA Interleukin 6 Antisense RNA 1 Promotes Inflammatory Effects in Lung Macrophages via Exosomes Through the S100A9/TLR4 Pathway in Chronic Obstructive Pulmonary Disease Progression
by: Erkang Yi, et al.
Published: (2025)

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
by: Yunfang Yu, et al.
Published: (2025)

Depletion of Fat Mass and Obesity‐Associated Protein (FTO) Drives Heterochromatin Loss via Lysine Acetyltransferase 8 (KAT8)‐Mediated Remodeling and Spacing Factor 1 (RSF1) Acetylation in Skin Aging
by: Fan Wang, et al.
Published: (2025)

PD‐1/PD‐L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First‐Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
by: Riqing Huang, et al.
Published: (2025)

Partial reduction of interleukin‐33 signaling improves senescence and renal injury in diabetic nephropathy
by: Li Chen, et al.
Published: (2024)

Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
by: Zhonghan Zhang, et al.
Published: (2024)

Spatially Characterized Aortic Proteome Reveals Novel Regional Signatures and Glucocorticoid Receptor/Dipeptidase 1 Axis in Diabetic Vasculopathy
by: Chak Kwong Cheng, et al.
Published: (2026)

H 2 S donor S‐propargyl‐cysteine for skin wound healing improvement via smart transdermal delivery
by: Xiaoqing Zhao, et al.
Published: (2024)

Separase Inhibition Enhances Gefitinib Sensitivity of Lung Cancer via PTBP1/TAK1/RIPK1‐Mediated PANoptosis
by: Zhouyangfan Peng, et al.
Published: (2025)

Microbiome‐Based Clustering Identifies Glycemic Control‐Related Subtypes in Youth With Recent‐Onset Type 1 Diabetes
by: Huiling Tan, et al.
Published: (2026)

SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway
by: Xuan Wei, et al.
Published: (2025)

Efficacy of small molecules against the severe acute respiratory syndrome coronavirus 2 XBB1.16 and XBB1.9.2.1
by: Lunzhi Yuan, et al.
Published: (2024)

N6‐Methyladenosine Modification of circIST1 Promotes Hypoxia‐Inducible Factor α–mediated Glycolysis and Progression in Hepatocellular Carcinoma
by: Yangyang Zhan, et al.
Published: (2026)

RNA Modifications in Health and Disease
by: Shiqi Li, et al.
Published: (2025)

Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
by: Siyu Wang, et al.
Published: (2024)

BCR–ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ
by: Xiaocui Lu, et al.
Published: (2026)